[1]
K. V. Levandowska, “IMPROVING THE USE OF MYOCARDIAL CYTOPROTECTORS AS A METABOLIC THERAPY OF PATIENTS WITH DECOMPENSATED HEART FAILURE IN THE EARLY AND LATE POST-INFARCE PERIOD”, pulse, no. 18 (66), pp. 69–83, Dec. 2022.